Maurizio Del Poeta

Source: Wikipedia, the free encyclopedia.
Maurizio Del Poeta
Born
Maurizio Del Poeta

February 2, 1966
Macerata, Italy
Alma mater
University of Ancona
OccupationMedical researcher
Known forFungal pathogenesis, sphingolipids, antifungal drug design
Scientific career
InstitutionsStony Brook University

Maurizio Del Poeta is a Distinguished Professor in the Department of Microbiology and Immunology at the Stony Brook University Renaissance School of Medicine. His research focuses on novel anti-fungal drug discovery and lipid-mediated fungal pathogenesis.

Early life

Maurizio Del Poeta was born in

infectious disease,[1] as well as undergoing post-doctoral training in the Division of Infectious Diseases under Professor John Perfect in the area of fungal pathogenesis.[2]

Discovery of sphingolipid-mediated fungal pathogenesis

While performing his training at

immunomodulator not only against infection but also against cancer.[5] In 2003, while at MUSC, Del Poeta was elected a Burroughs Wellcome New Investigator in Pathogenesis of Infectious Diseases.[6] Following this award, Del Poeta was later promoted to Associate Professor with tenure in 2006 and to full Professor with tenure in 2011.[1]

Subsequent career

In 2012, Del Poeta was recruited by the Department of Microbiology and Immunology at Stony Brook University to continue his research program on the study of lipids, metabolism, and imaging in Infectious Diseases with a focus on pathogenic fungal infections.[citation needed] Under his leadership, the infectious disease research and care at Stony Brook has expanded, including the establishment of a new lipidomics and metabolomics core facility to collect and analyze biological data at the University.[citation needed]

Soon after his arrival to Stony Brook University, Del Poeta engaged with the Center of Biotechnology and through their entrepreneurship-in-residency program, he co-founded MicroRid Technologies Inc.[7] with John B. McCarthy and John Mallamo, a start-up company that has the primary goal to research and develop new classes of anti-fungal compounds.[8] The research from this company helps to advance infectious disease research and rapidly translate basic research findings into new clinical tools and immunotherapies.[citation needed]

Research contributions, honors, and awards

In the field of bioactive

SUNY.[14]

Personal life

While at Duke University, Del Poeta met his wife Chiara Luberto,[8] a fellow scientist and biomedical researcher who also made seminal contributions to the sphingolipid field. Both Del Poeta and Dr. Luberto hold professorships at Stony Brook University, and they have two sons.[8]

References

  1. ^ a b c d "Loop | Maurizio Del Poeta". loop.frontiersin.org. Retrieved 8 September 2023.
  2. ^ "Duke Researchers Find Existing Drugs Can Stop Fungus That Attacks AIDS Patients". Duke Health. 14 May 1997. Retrieved 8 September 2023.
  3. PMID 11157776
    .
  4. .
  5. .
  6. ^ 2003 Annual Report (PDF) (Report). Research Triangle Park NC: Burroughs Wellcome Fund. 2003. p. 53. Archived (PDF) from the original on 6 December 2022.
  7. ^ "Stony Brook Startup Featured at University and Innovation Entrepreneurship Showcase in Washington, DC | Stony Brook Matters". news.stonybrook.edu. Retrieved 2021-06-04.
  8. ^ a b c Dunaief, Daniel (22 January 2013). "SBU's Maurizio Del Poeta conducts fungal research | TBR News Media". Retrieved 2021-06-04.
  9. ^ "Maurizio Del Poeta". scholar.google.com. Retrieved 2021-06-04.
  10. .
  11. ^ "The American Society for Clinical Investigation". Retrieved 2021-06-04.
  12. ^ "Two Physicians Recognized for Novel Work in Cancer, Antifungal Research Named to AAP |". SBU News. 2017-04-20. Retrieved 2021-06-04.
  13. ^ "65 Fellows Elected into the American Academy of Microbiology". ASM.org. Retrieved 2021-06-04.
  14. ^ "Five SBU Faculty Rise to the Rank of SUNY Distinguished Professor | Stony Brook Matters". news.stonybrook.edu. Retrieved 2021-06-04.

External links